SITC is pleased to announce the publication of our newest guideline, "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer."
Clinicians will find this guideline an invaluable resource to assist in navigating the challenging issues that sometimes arise during the treatment of advanced nonmelanoma skin cancer, including treatment selection, immunosuppressed patient populations, toxicity management, assessment of atypical responses, and quality of life and survivorship concerns. This guideline covers immunotherapy for the treatment of Merkel cell carcinoma, cutaneous squamous cell carcinoma, basal cell carcinoma, and rare types of nonmelanoma skin cancer as well .
The manuscript, the latest in the ongoing series of SITC Cancer Immunotherapy Guidelines, is available now in the Journal for ImmunoTherapy of Cancer (JITC), the society’s open access, peer-reviewed online journal and a mobile version with interactive tools will be available in app soon. Check the notifications in the app to be alerted when the mobile version of the guideline becomes available.
Key features of the new guideline include:
- Expert panel recommendations on diagnosis and initial staging, treatment selection, response monitoring and surveillance, and considerations for special patient populations
- An immunotherapy treatment algorithm for Merkel cell carcinoma, cutaneous squamous cell carcinoma, and basal cell carcinoma
- Discussion of emerging immunotherapy strategies for nonmelanoma skin cancer
- Quick-reference tables summarizing pivotal trial data for approved immunotherapy agents for nonmelanoma skin cancer
SITC is also pleased to offer free webinars featuring Expert Panel members from SITC's Nonmelanoma Skin Cancer Immunotherapy Guideline. These educational offerings are designed for healthcare providers who treat cancer patients including oncologists, physicians, disease specialists, registered nurses, nurse practitioners, pharmacists and physician assistants.
The on-demand webinars are available here.